← All trials
NCT06567808
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2024
- Primary completion
- Apr 30, 2028
- Completion date
- Jul 30, 2028
- First posted
- Aug 23, 2024
- Last posted
- Sep 27, 2024
- Enrollment
- 38000
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Hamilton Health Sciences CorporationLead sponsor
- Canadian Institutes of Health Research (CIHR)Collaborator
- Hamilton Health Sciences CorporationOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.